| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,547 |
12,693 |
$1.19M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,758 |
8,749 |
$697K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,677 |
5,393 |
$437K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,091 |
2,362 |
$276K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
985 |
833 |
$243K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,378 |
1,112 |
$217K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,897 |
6,525 |
$180K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,580 |
2,265 |
$179K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,282 |
2,438 |
$155K |
| 80053 |
Comprehensive metabolic panel |
6,075 |
4,603 |
$141K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,320 |
974 |
$104K |
| G0378 |
Hospital observation service, per hour |
4,033 |
1,539 |
$95K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,211 |
1,634 |
$93K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,489 |
3,908 |
$76K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,478 |
2,279 |
$60K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
429 |
84 |
$35K |
| 36415 |
Collection of venous blood by venipuncture |
1,037 |
725 |
$31K |
| 81001 |
|
5,406 |
4,495 |
$30K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,070 |
875 |
$28K |
| 71045 |
Radiologic examination, chest; single view |
4,761 |
3,852 |
$22K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
417 |
344 |
$20K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
581 |
550 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,098 |
10,233 |
$19K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,316 |
3,867 |
$18K |
| 87070 |
|
1,116 |
1,010 |
$16K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,155 |
2,221 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
1,280 |
1,135 |
$16K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
794 |
609 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,115 |
5,293 |
$15K |
| A9270 |
Non-covered item or service |
3,689 |
1,721 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,105 |
4,003 |
$11K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
408 |
103 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,737 |
1,851 |
$10K |
| 85610 |
|
3,417 |
2,613 |
$8K |
| 85730 |
|
3,104 |
2,385 |
$8K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,860 |
1,257 |
$8K |
| 84703 |
|
3,333 |
2,990 |
$8K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
13 |
$8K |
| 72131 |
|
158 |
118 |
$7K |
| J2704 |
Injection, propofol, 10 mg |
744 |
520 |
$7K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,031 |
1,016 |
$6K |
| 84484 |
|
4,038 |
2,522 |
$6K |
| 82962 |
|
1,471 |
560 |
$5K |
| 83735 |
|
3,396 |
2,295 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,740 |
2,235 |
$4K |
| 85027 |
|
1,746 |
1,226 |
$4K |
| 80076 |
|
2,884 |
2,362 |
$4K |
| 73562 |
|
294 |
226 |
$4K |
| J3490 |
Unclassified drugs |
33 |
17 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,646 |
1,342 |
$3K |
| 71250 |
|
20 |
12 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,825 |
2,071 |
$3K |
| 83690 |
|
2,687 |
2,221 |
$3K |
| 70486 |
|
34 |
24 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
96 |
87 |
$2K |
| A4217 |
Sterile water/saline, 500 ml |
88 |
68 |
$2K |
| 96376 |
|
1,307 |
698 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,296 |
800 |
$2K |
| 97162 |
|
52 |
40 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,353 |
2,013 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
465 |
342 |
$2K |
| 86850 |
|
695 |
541 |
$2K |
| 94664 |
|
653 |
532 |
$2K |
| 86901 |
|
990 |
778 |
$2K |
| 86900 |
|
990 |
778 |
$2K |
| 73030 |
|
151 |
123 |
$2K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
67 |
28 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
465 |
345 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
13 |
13 |
$1K |
| 84702 |
|
101 |
88 |
$1K |
| 73610 |
|
117 |
110 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
39 |
36 |
$1K |
| 73630 |
|
160 |
141 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
156 |
85 |
$1K |
| 73110 |
|
33 |
26 |
$736.95 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
547 |
522 |
$486.95 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
723 |
495 |
$422.80 |
| 73130 |
|
33 |
24 |
$382.93 |
| 85379 |
|
208 |
185 |
$372.24 |
| 83880 |
|
459 |
346 |
$358.37 |
| J7050 |
Infusion, normal saline solution, 250 cc |
400 |
211 |
$332.07 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
397 |
328 |
$320.99 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
273 |
212 |
$320.99 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13 |
12 |
$303.45 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
23 |
13 |
$302.59 |
| 87040 |
|
320 |
172 |
$264.42 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
343 |
252 |
$255.96 |
| 87186 |
|
425 |
310 |
$141.11 |
| 87077 |
|
199 |
139 |
$101.86 |
| 84443 |
Thyroid stimulating hormone (TSH) |
299 |
243 |
$78.32 |
| 83605 |
|
282 |
205 |
$39.25 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
217 |
210 |
$23.94 |
| J2060 |
Injection, lorazepam, 2 mg |
201 |
148 |
$19.56 |
| J1644 |
Injection, heparin sodium, per 1000 units |
98 |
51 |
$12.03 |
| 87400 |
|
17 |
16 |
$8.31 |
| 82550 |
|
53 |
36 |
$4.83 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
94 |
57 |
$4.64 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
160 |
122 |
$1.13 |
| 72170 |
|
32 |
24 |
$0.00 |
| 85652 |
|
16 |
13 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
112 |
108 |
$0.00 |
| C1769 |
Guide wire |
13 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
19 |
12 |
$0.00 |
| 84100 |
|
236 |
162 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
297 |
244 |
$0.00 |
| 90715 |
|
13 |
12 |
$0.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
47 |
12 |
$0.00 |
| 80306 |
|
29 |
24 |
$0.00 |
| 81025 |
|
28 |
28 |
$0.00 |
| 87420 |
|
53 |
52 |
$0.00 |